Objective@#To investigate the clinical features and
prognostic factors of extrahepatic biliary neuroendocrine
neoplasms(EB-NENs).@*
Methods@#The clinical data and
survival of 21
patients with EB-NENs admitted from May 2014 to May 2018 were analyzed retrospectively.@*Results@#These 21 EB-NENs
patients accounted for 1.6% (21/1313) of all
biliary tract neoplasms treated during the study period. Seven (33.3%) cases had
lymph node metastasis. Five (23.8%) suffered from distant
metastasis. The follow up
time was (4~46.5) months with median
survival time of (23.23 ±4.17) months. Univariate
analysis showed that the
risk factors for
survival were
tumor TNM stage (χ2=9.066, P=0.003),
lymph node metastasis(χ2=6.399, P=0.011) and distant
metastasis (χ2=9.808, P=0.002). By
multivariate analysis, independent
risk factors were
tumor TNM stage(P=0.008, RR=3.003, 95% CI 1.332~6.774),
lymph node metastasis(P=0.023, RR=5.382, 95% CI 1.261~22.971) and distant
metastasis or not(P=0.007, RR=7.423, 95% CI 1.730~31.851).@*Conclusion@#EB-NENs was a rare malignant
tumor with poor
prognosis.
Tumor TNM stage,
lymph node metastasis and distant
metastasis were independent
prognostic factors for EB-NENs
patients.